These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10180369)

  • 1. Unequal randomisation can improve the economic efficiency of clinical trials.
    Torgerson D; Campbell M
    J Health Serv Res Policy; 1997 Apr; 2(2):81-5. PubMed ID: 10180369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of unequal randomisation in clinical trials--An update.
    Peckham E; Brabyn S; Cook L; Devlin T; Dumville J; Torgerson DJ
    Contemp Clin Trials; 2015 Nov; 45(Pt A):113-22. PubMed ID: 26027788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of unequal randomisation ratios in clinical trials: a review.
    Dumville JC; Hahn S; Miles JN; Torgerson DJ
    Contemp Clin Trials; 2006 Feb; 27(1):1-12. PubMed ID: 16236557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of unequal randomisation to aid the economic efficiency of clinical trials.
    Torgerson DJ; Campbell MK
    BMJ; 2000 Sep; 321(7263):759. PubMed ID: 10999916
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative costs and activity from a sample of UK clinical trials units.
    Hind D; Reeves BC; Bathers S; Bray C; Corkhill A; Hayward C; Harper L; Napp V; Norrie J; Speed C; Tremain L; Keat N; Bradburn M
    Trials; 2017 May; 18(1):203. PubMed ID: 28464930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
    Doshi JA; Glick HA; Polsky D
    Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.
    Dakin H; Gray A
    Stat Med; 2017 Aug; 36(18):2814-2830. PubMed ID: 28470760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials.
    Detsky AS
    Stat Med; 1990; 9(1-2):173-84. PubMed ID: 2111932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and interpretation of cost data in randomised controlled trials: review of published studies.
    Barber JA; Thompson SG
    BMJ; 1998 Oct; 317(7167):1195-200. PubMed ID: 9794854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.
    Backhouse ME
    Pharmacoeconomics; 2002; 20(15):1061-77. PubMed ID: 12456201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A framework for cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW
    Health Econ; 2001 Jun; 10(4):303-15. PubMed ID: 11400253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal and maximin sample sizes for multicentre cost-effectiveness trials.
    Manju MA; Candel MJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):513-39. PubMed ID: 25656551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size.
    Campbell MK; Mollison J; Grimshaw JM
    Stat Med; 2001 Feb; 20(3):391-9. PubMed ID: 11180309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient use of endpoints in clinical trials: a clinical perspective.
    Terrin ML
    Stat Med; 1990; 9(1-2):155-60. PubMed ID: 2111931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost efficiency in study planning and completion. How many cases? How many controls?
    Rosenberg MJ
    Am J Med; 1983 Nov; 75(5):833-8. PubMed ID: 6416065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trial.
    Willan AR
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):543-9. PubMed ID: 15167155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
    Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
    Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculating sample sizes for cluster randomized trials: we can keep it simple and efficient!
    van Breukelen GJ; Candel MJ
    J Clin Epidemiol; 2012 Nov; 65(11):1212-8. PubMed ID: 23017638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.